T. Uhlig

969 total citations
18 papers, 707 citations indexed

About

T. Uhlig is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, T. Uhlig has authored 18 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Rheumatology, 3 papers in Hematology and 2 papers in Immunology. Recurrent topics in T. Uhlig's work include Rheumatoid Arthritis Research and Therapies (16 papers), Systemic Lupus Erythematosus Research (6 papers) and Spondyloarthritis Studies and Treatments (3 papers). T. Uhlig is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (16 papers), Systemic Lupus Erythematosus Research (6 papers) and Spondyloarthritis Studies and Treatments (3 papers). T. Uhlig collaborates with scholars based in Norway, Netherlands and Denmark. T. Uhlig's co-authors include Tore K Kvien, L M Smedstad, Sigrid Ødegård, Petter Mowinckel, D. van der Heijde, Theodore Pincus, Tore K. Kvien, Øystein Førre, A Glennås and T. K. Kvien and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Scandinavian Journal of Rheumatology.

In The Last Decade

T. Uhlig

16 papers receiving 679 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Uhlig Norway 11 536 218 151 105 78 18 707
Savia de Souza United Kingdom 11 364 0.7× 138 0.6× 97 0.6× 44 0.4× 63 0.8× 23 626
Necatı Çakir Türkiye 14 276 0.5× 101 0.5× 106 0.7× 89 0.8× 101 1.3× 31 592
Inger Jorid Berg Norway 15 680 1.3× 233 1.1× 285 1.9× 58 0.6× 65 0.8× 35 789
J. M. W. Hazes Netherlands 10 375 0.7× 108 0.5× 144 1.0× 63 0.6× 32 0.4× 20 574
H. C. M. Haanen Netherlands 10 534 1.0× 203 0.9× 67 0.4× 65 0.6× 109 1.4× 13 851
K Pugner United Kingdom 6 477 0.9× 161 0.7× 61 0.4× 57 0.5× 170 2.2× 13 756
Karel Ronday Netherlands 8 449 0.8× 304 1.4× 57 0.4× 31 0.3× 52 0.7× 15 630
A. Collado Spain 13 469 0.9× 107 0.5× 194 1.3× 109 1.0× 110 1.4× 25 698
Rafael Ariza‐Ariza Spain 13 532 1.0× 216 1.0× 225 1.5× 23 0.2× 42 0.5× 26 689
Simone Parisi Italy 12 212 0.4× 77 0.4× 146 1.0× 49 0.5× 60 0.8× 61 578

Countries citing papers authored by T. Uhlig

Since Specialization
Citations

This map shows the geographic impact of T. Uhlig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Uhlig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Uhlig more than expected).

Fields of papers citing papers by T. Uhlig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Uhlig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Uhlig. The network helps show where T. Uhlig may publish in the future.

Co-authorship network of co-authors of T. Uhlig

This figure shows the co-authorship network connecting the top 25 collaborators of T. Uhlig. A scholar is included among the top collaborators of T. Uhlig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Uhlig. T. Uhlig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hammer, Hilde Berner, Silvia Rollefstad, Lene Terslev, et al.. (2021). OP0204 URATE CRYSTAL DEPOSITIONS ARE ASSOCIATED WITH INFLAMMATORY MARKERS AND CAROTID PLAQUES INDICATING SUBCLINICAL INFLAMMATION IN GOUT; BASELINE RESULTS FROM THE NOR-GOUT STUDY. Annals of the Rheumatic Diseases. 80. 123–123. 1 indexed citations
2.
Lillegraven, Siri, Anna‐Birgitte Aga, Inge Christoffer Olsen, et al.. (2020). OP0019 STABLE VERSUS TAPERED AND WITHDRAWN TREATMENT WITH TUMOR NECROSIS FACTOR INHIBITOR IN RHEUMATOID ARTHRITIS REMISSION (ARCTIC REWIND): A RANDOMISED, OPEN-LABEL, PHASE 4, NON-INFERIORITY TRIAL. Annals of the Rheumatic Diseases. 79. 14–15. 1 indexed citations
3.
Ramiro, Sofía, Polina Putrik, Yvonne van Eijk‐Hustings, et al.. (2018). The eumusc.net standards of care for rheumatoid arthritis: importance and current implementation according to patients and healthcare providers in the Netherlands.. PubMed. 36(2). 275–283. 1 indexed citations
5.
Haavardsholm, Espen A., Anna‐Birgitte Aga, Inge Christoffer Olsen, et al.. (2016). OP0177 Ultrasound in The Management of Rheumatoid Arthritis: Results from The Randomized Controlled Arctic Trial. Annals of the Rheumatic Diseases. 75. 123–123. 1 indexed citations
6.
Cuperus, Nienke, T. P. M. Vliet Vlieland, Nina Brodin, et al.. (2015). Characterizing the concept of activity pacing as a non-pharmacological intervention in rheumatology care: results of an international Delphi survey. Scandinavian Journal of Rheumatology. 45(1). 66–74. 10 indexed citations
7.
Østergaard, Mikkel, Karin Franck‐Larsson, Marjatta Leirisalo‐Repo, et al.. (2014). In rheumatoid arthritis patients with stable low disease activity on etanercept plus methotrexate, continuation of etanercept is clinically and radiographically superior to discontinuation: results from a randomized, double-blind clinical trial. 43. 30–31.
8.
Moe, Rikke Helene, et al.. (2012). Disease impact of hand OA compared with hip, knee and generalized disease in specialist rheumatology health care. Lara D. Veeken. 52(1). 189–196. 14 indexed citations
9.
Heijde, D. van der, et al.. (2010). SHOULD ACPA STATUS BE REASSESSED IN PATIENTS WITH EARLY ARTHRITIS: RESULTS FROM FOLLOW-UP EXAMINATIONS IN PATIENTS WITH ARTHRITIS OF LESS THAN 16 WEEKS DURATION. Scandinavian Journal of Rheumatology. 39. 22–22. 1 indexed citations
10.
Lie, E., D. van der Heijde, T. Uhlig, et al.. (2009). Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 69(4). 671–676. 88 indexed citations
11.
Uhlig, T., Tore K. Kvien, & Theodore Pincus. (2008). Test–retest reliability of disease activity core set measures and indices in rheumatoid arthritis. Annals of the Rheumatic Diseases. 68(6). 972–975. 71 indexed citations
12.
Ødegård, Sigrid, Magne K. Fagerhol, Robert Landewé, et al.. (2007). Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis. Annals of the Rheumatic Diseases. 66(8). 1093–1097. 124 indexed citations
13.
Ødegård, Sigrid, Arnstein Finset, Petter Mowinckel, T. K. Kvien, & T. Uhlig. (2007). Pain and psychological health status over a 10-year period in patients with recent onset rheumatoid arthritis. Annals of the Rheumatic Diseases. 66(9). 1195–1201. 100 indexed citations
14.
Uhlig, T., et al.. (2004). Is rheumatoid arthritis disappearing?. Annals of the Rheumatic Diseases. 64(1). 7–10. 50 indexed citations
15.
Kvien, Tore K & T. Uhlig. (2004). The Oslo experience with arthritis registries.. PubMed. 21(5 Suppl 31). S118–22. 29 indexed citations
16.
Uhlig, T., L M Smedstad, Per Vaglum, et al.. (2000). The course of rheumatoid arthritis and predictors of psychological, physical and radiographic outcome after 5 years of follow‐up. Lara D. Veeken. 39(7). 732–741. 70 indexed citations
17.
Hagen, Kåre Birger, L M Smedstad, T. Uhlig, & Tore K Kvien. (1999). The responsiveness of health status measures in patients with rheumatoid arthritis: comparison of disease-specific and generic instruments.. PubMed. 26(7). 1474–80. 41 indexed citations
18.
Uhlig, T., Tore K Kvien, A Glennås, L M Smedstad, & Øystein Førre. (1998). The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway.. PubMed. 25(6). 1078–84. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026